Sort by
Genetic characterization of Dibothriocephalus latus and Dibothriocephalus dendriticus (Cestoda: Diphyllobothriidae) from Chile based on haplotype analysis using mitochondrial DNA markers.

Dibothriocephalus latus and Dibothriocephalus dendriticus are found throughout the temperate and sub-arctic zones of the northern hemisphere, but they are also found in the southern core countries of South America, Chile and Argentina. Genetic characteristics of D. latus and D. dendriticus from South America have yet to be fully defined. The present study aimed to understand the genetic characteristics of D. latus and D. dendriticus from Chile by haplotype network analysis of mitochondrial cytochrome c oxidase subunit I gene (cox1) and cytochrome b gene (cob), as well as their origins. Dibothriocephalus latus and D. dendriticus plerocercoid larvae were obtained from feral and/or wild salmonids captured in Lake Llanquihue in Región de Los Lagos, and Lake Panguipulli in Región de Los Ríos, located south of central Chile. Haplotype analysis of D. latus revealed that H1 in cox1 and H2 in cob are the key haplotypes common to D. latus across the world, including Chile, and both genes exhibited limited genetic diversity in D. latus. It was assumed that D. latus was brought into South America by European and Russian immigrants in the 19th century as previously reported. In contrast, both the cox1 and cob of D. dendriticus display considerable genetic diversity, with no common haplotypes between D. dendriticus populations from Chile and the northern hemisphere. More intriguingly, two cob haplotypes (H24, H25) detected in Chilean D. dendriticus were closely linked to haplotypes (H30, H31) detected in North American D. dendriticus, strongly implying that D. dendriticus in Chile was brought by piscivorous migrating birds from North America. It has also been estimated that the D. dendriticus from Chile genetically diverged from the D. dendriticus from the northern hemisphere approximately 1.11 million years ago, long before humans migrated to the southern parts of South America.

Relevant
A new species of <i>Janiralata</i> Menzies, 1951 (Isopoda: Janiridae) from Japanese bathyal waters, with a review of the associations with invertebrates among the species of <i>Janiralata</i>

Abstract Isopods of the genus Janiralata Menzies, 1951 (Asellota: Janiridae) are known from shallow and deep waters of the Northern Hemisphere. Most species are free-living, but some are symbiotic on the surface of other benthic invertebrates. We obtained from three beam- and four otter-trawl hauls 18 Janiralata asellote specimens from the bathyal zone off the Pacific coasts of Tohoku, northeastern Japan. Partial nucleotide sequences of the mitochondrial cytochrome c oxidase subunit I (COI) gene (505 bp) were determined for 16 of the 18 collected specimens. Non-significant genetic differences (&amp;lt; 0.8%) indicated that the individuals were conspecifics. Morphological analysis indicated that all the specimens belonged to a single species, Janiralata planasp. nov. based on the unique morphology of the anterolateral and distolateral projections on the head and pleotelson, surface and lateral margins of the body, antennula article 1, and of the male pleopod 1. Six of the 18 collected specimens were found attached to the surface of an unidentified sea anemone (Hormathiidae), ten to the solasterid starfish Crossaster borealis Fisher, 1906 and two were obtained from the bottom sediment. Three COI haplotypes of the new species were shared by individuals from two neighboring sites, which suggests that genetic isolation occurs on a relatively narrow horizontal scale, although the bathymetric distribution range was rather wide. We describe a case study of the geographic and bathymetric distributions of an asellote species with low dispersal ability and its genetically differentiated populations. Such approach could help elucidate the diversity and distribution of deep-sea organisms and their diversification processes.

Open Access
Relevant
Establishment of the Life Cycle of &lt;i&gt;Philometroides seriolae&lt;/i&gt; (Nematoda: Philometridae) Using Surrogate Copepod Intermediate Host

Philometoides seriolae is a large nematode parasite in the skeletal musculature of Japanese amberjack Seriola quinqueradiata. ​Philometrid nematodes generally use copepods as the intermediate host. ​However, the life cycle of P. seriolae remains unknown, including its intermediate host. ​Instead of finding the true intermediate host from natural environments, we used the copepod Tigriopus japonicus as a surrogate host to experimentally complete life cycle of the nematode. ​Fresh first stage larvae were obtained from the uterus of mature P. seriolae from naturally infected Japanese amberjack. ​Tigriopus japonicus actively fed on hatched larvae, which established infection in the hemocoel at a consistently high rate. ​Twenty-three to 27 days later, the infected T. japonicus were fed to artificially produced juvenile Japanese amberjack. ​About 11 months later, adult female nematodes were recovered from the skeletal musculature of the experimentally infected fish. ​This is the first report of experimental completion of life cycle from hatched larvae to adults in marine philometrid species. ​It would take more than a year for P. seriolae females in the definitive host to be able to produce and disseminate larvae, as those recovered from the experimental fish were still young with eggs in the uterus.

Relevant
Efficacy of blonanserin transdermal patch on terminal delirium in patients with respiratory diseases

BackgroundDelirium is a common distressing symptom observed in patients with terminal respiratory diseases and is treated with antipsychotic medications such as haloperidol. Its management is difficult, especially in palliative home care, because its administration is limited to oral or injection methods. Recently, the blonanserin transdermal patch was developed as the first antipsychotic percutaneous agent. After it became available, we recognized its potential for the management of delirium and the alleviation of uncontrolled dyspnea in clinical practice. Thus, this study aimed to assess its efficacy in patients with terminal respiratory diseases. MethodsThis retrospective study included 113 patients with respiratory diseases who were cared for at home. The efficacy was evaluated through the prevalence of terminal delirium before and after its treatment initiation for uncontrolled dyspnea. ResultsBlonanserin transdermal patch treatment for uncontrolled dyspnea improved the prevalence and severity of terminal delirium (from 70.4% to 16.3%, p < 0.001) and reduced the number of doctors' visits to patients’ homes within a week before their death (from 4.0 to 3.0, p = 0.086). A sub-group analysis of 23 patients with interstitial pneumonia revealed that the treatment prevented dyspnea progression by inhibiting terminal delirium. ConclusionsBlonanserin transdermal patch performed similarly to haloperidol, as previously reported, for managing terminal delirium. Our study suggests that a blonanserin transdermal patch potentially prevents terminal delirium and alleviates uncontrolled dyspnea in patients with respiratory diseases. Our findings encourage clinical trials to evaluate the safety and efficacy of blonanserin transdermal patches for patients with terminal illnesses.

Relevant
Generation of β-like cell subtypes from differentiated human induced pluripotent stem cells in 3D spheroids.

Since the identification of four different pancreatic β-cell subtypes and bi-hormomal cells playing a role in the diabetes pathogenesis, the search for in vitro models that mimics such cells heterogeneity became a key priority in experimental and clinical diabetology. We investigated the potential of human induced pluripotent stem cells to lead to the development of the different β-cells subtypes in honeycomb microwell-based 3D spheroids. The glucose-stimulated insulin secretion confirmed the spheroids functionality. Then, we performed a single cell RNA sequencing of the spheroids. Using a knowledge-based analysis with a stringency on the pancreatic markers, we extracted the β-cells INS+/UCN3+ subtype (11%; β1-like cells), the INS+/ST8SIA1+/CD9- subtype (3%, β3-like cells) and INS+/CD9+/ST8SIA1-subtype (1%; β2-like cells) consistently with literature findings. We did not detect the INS+/ST8SIA1+/CD9+ cells (β4-like cells). Then, we also identified four bi-hormonal cells subpopulations including δ-like cells (INS+/SST+, 6%), γ-like cells (INS+/PPY+, 3%), α-like-cells (INS+/GCG+, 6%) and ε-like-cells (INS+/GHRL+, 2%). Using data-driven clustering, we extracted four progenitors' subpopulations (with the lower level of INS gene) that included one population highly expressing inhibin genes (INHBA+/INHBB+), one population highly expressing KCNJ3+/TPH1+, one population expressing hepatocyte-like lineage markers (HNF1A+/AFP+), and one population expressing stem-like cell pancreatic progenitor markers (SOX2+/NEUROG3+). Furthermore, among the cycling population we found a large number of REST+ cells and CD9+ cells (CD9+/SPARC+/REST+). Our data confirm that our differentiation leads to large β-cell heterogeneity, which can be used for investigating β-cells plasticity under physiological and pathophysiological conditions.

Relevant